9.19
0.07 (0.77%)
| Previous Close | 9.12 |
| Open | 8.97 |
| Volume | 11,771,207 |
| Avg. Volume (3M) | 9,771,001 |
| Market Cap | 6,274,521,600 |
| Price / Earnings (Forward) | 12.36 |
| Price / Sales | 0.990 |
| Price / Book | 1.16 |
| 52 Weeks Range |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | -0.75 |
|
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 103.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 31 Mar 2026 | 14,000,000 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |